日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial

比马格鲁单抗联合索马鲁肽或单独使用治疗肥胖症:一项随机 II 期试验

Heymsfield, Steven B; Aronne, Louis J; Montgomery, Penelope; Klickstein, Lloyd B; Coleman, Laura A; Dole, Kiran; Mindeholm, Linda; Spruill, Susan; Li, Xingyuan; Attie, Kenneth M

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

活化的 ATF6α 是肝肿瘤的驱动因子,可限制免疫监视。

Li Xin, Lebeaupin Cynthia, Kadianaki Aikaterini, Druelle-Cedano Clementine, Vesper Niklas, Rennert Charlotte, Huguet-Pradell Júlia, Gomez Ramos Borja, Fan Chaofan, Piecyk Robert Stefan, Zizmare Laimdota, Ramadori Pierluigi, Li Luqing, Frick Lukas, Qiu Menjie, Zhang Cangang, Martins Nascentes Melo Luiza, Ranvir Vikas Prakash, Shen Peng, Hanselmann Johannes, Kosla Jan, Fernández-Vaquero Mirian, Vucur Mihael, Baskaran Praveen, Bao Xuanwen, Coleman Olivia I, Tang Yingyue, Cetin Miray, Chen Zhouji, Jang Insook, Del Prete Stefania, Rahbari Mohammad, Zhang Peng, Pham Timothy V, Hou Yushan, Sun Aihua, Gu Li, Kim Laura C, Rothermel Ulrike, Heide Danijela, Ali Adnan, Gallage Suchira, Talvard-Balland Nana, Piqué-Gili Marta, Gris-Oliver Albert, Bevilacqua Alessio, Schlicker Lisa, Duffey Alec, Unger Kristian, Szydlowska Marta, Hetzer Jenny, Odom Duncan T, Machauer Tim, Bucci Daniele, Sant Pooja, Lee Jun-Hoe, Rösler Jonas, Meckelmann Sven W, Schreck Johannes, Murray Sue, Simon M Celeste, Nahnsen Sven, Schulze Almut, Ho Ping-Chih, Jugold Manfred, Breuhahn Kai, Mallm Jan-Philipp, Schirmacher Peter, Roth Susanne, Rahbari Nuh, Tschaharganeh Darjus F, Roessler Stephanie, Goeppert Benjamin, Bengsch Bertram, Andrieux Geoffroy, Boerries Melanie, Malek Nisar P, Prinz Marco, Weber Achim, Zeiser Robert, Tamayo Pablo, Bronsert Peter, Kurowski Konrad, Thimme Robert, Yuan Detian, Carretero Rafael, Luedde Tom, Pinyol Roser, Hartmann Felix J, Karin Michael, Tasdogan Alpaslan, Trautwein Christoph, Mall Moritz, Hofmann Maike, Llovet Josep M, Haller Dirk, Kaufman Randal J, Heikenwälder Mathias

From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum

从尼古丁到具有强效体内疗效和广谱抗冠状病毒作用的SARS-CoV-2抗病毒药物

Khatua, Kaustav; Atla, Sandeep; Coleman, Demonta; Blankenship, Lauren R; Alugubelli, Yugendar R; Vulupala, Veerabhadra; Guo, Xuejiao Shirley; Xia, Hongjie; Kalveram, Birte K; Walker, David H; Hurst, Brett L; Kumar, Sathish; Cho, Chia-Chuan D; Sharma, Shivangi; Yang, Kai; Rabie, Dorsa; Nyalata, Satyanarayana; Neuman, Benjamin W; Xie, Xuping; Xu, Shiqing; Liu, Wenshe Ray

Molecular Analysis of Mixed-Type and Branch-Duct Intraductal Papillary Mucinous Neoplasms

混合型和分支导管型导管内乳头状黏液性肿瘤的分子分析

Kannan, Amudhan; Murimwa, Gilbert Z; Mansour, John C; Whitham, Zachary A; Jones, Alex R; Sheth, Megha K; Abbas, Ali; Deverakonda, Abhi; Sawas, Tarek; Ellis, Daniel J; Vanderveldt, Hendrikus S; Coleman, Veronica; Foley, Samantha; Tavakkoli, Anna; Goldschmeidt, Markus; Rajamohan, Naveen; Khatri, Gaurav; Brand, Randall E; Nikiforova, Marina N; Paniccia, Alessandro; Zureikat, Amer H; Lee, Kenneth K W; Fleming, Jason B; Zeh, Herbert J; Kubiliun, Nisa M; Singhi, Aatur D; Polanco, Patricio M

APP-mediated intracellular signaling rescues sleep impairment and blood-brain barrier leakage in Alzheimer's disease mouse model

APP介导的细胞内信号传导可改善阿尔茨海默病小鼠模型的睡眠障碍和血脑屏障渗漏

Puech, Clémentine; Sadanand, Anjana; Coleman, Neil; Ikhane, Marilyn; Badran, Mohammad; Wang, Rong; Gozal, David; Parent, Angèle T

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)C1和C2子方案的结果

Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights

在复发性子宫内膜癌和卵巢癌患者中应用Copanlisib和Niraparib联合治疗(COPANIRA):疗效、毒性和转化研究进展

Brodsky, Allison L; Asare, Amma; Fellman, Bryan; Anderson, Kristin; Yao, Jun; Lee, Sanghoon; Tran, Hai; Xu, Xun; Liu, Jinsong; Celestino, Joseph; Hajek, Richard A; Morgan, Margaret B; Mohammad, Mohammad; Soliman, Pamela; Shafer, Aaron; Sood, Anil K; Bodurka, Diane; Fleming, Nicole D; Onstad Grinsfelder, Michaela; Milojevic, Ljiljana; Jazaeri, Amir A; Mills, Gordon B; Coleman, Robert L; Westin, Shannon N

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

GOG281/LOGS 研究的分子谱分析和肿瘤生物标志物分析:曲美替尼治疗复发/持续性低级别浆液性卵巢癌的阳性后期试验

Hollis, Robert L; Miller, Austin; Lankes, Heather A; Wong, Kwong-Kwok; Rodgers, William; Millan, David; Carty, Karen; Coleman, Robert L; Moore, Kathleen N; Alvarez Secord, Angeles; O'Malley, David M; Chan, John K; Hagemann, Andrea R; Gaillard, Stephanie; Guntupalli, Saketh R; Edelson, Mitchell I; Rose, Peter G; Dorigo, Oliver; Banerjee, Susana; Ewing, Ailith; Churchman, Michael; Sood, Anil K; Herrington, C Simon; Gourley, Charlie; Gershenson, David M

GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform.

GPA33 与 Claudin 18.2 在食管腺癌中形成独特的诊断靶标类别,从而能够开发出一种新型的基于 GPA33 抗体的检测平台。

Brydon Jack, Krejcir Radovan, Zavadil-Kokas Filip, Singh Ashita, Henek Tomas, Hernychova Lenka, Coleman Skye, Al Shboul Sofian, Hrabal Vaclav, Kuncova Zuzana, Mayordomo Marcos Yébenes, Arcimowicz Łukasz, Ball Kathryn L, Padariya Monikaben, Kalathiya Umesh, Vojtesek Borivoj, Hupp Ted, O'Neill J R

A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling

一项针对转移性胰腺癌的 XL888(HSP90 抑制剂)联合帕博利珠单抗的 Ib/II 期临床试验,并结合转化免疫分析。

Horvat, Natalie K; Diab, Maria; Phillips, Maggie J; McCook-Veal, Ashley; Grundy, Erin E; Alese, Olatunji B; Greene, Emily; Gbolahan, Olumide; Coleman, Kathleen; Doxie, Deon; Herting, Cameron J; Hammons, Jacklyn; Mahdi, Zaid; Switchenko, Jeffrey M; Paulos, Chrystal M; El-Rayes, Bassel F; Lesinski, Gregory B